Second generation, sirolimus‐eluting, bioresorbable Tyrocore scaffold implantation in patients with ST‐segment elevation myocardial infarction: Baseline OCT and 30‐day clinical outcomes – A FANTOM STEMI pilot study-Reference-Cited by-同舟云学术

Second generation, sirolimus‐eluting, bioresorbable Tyrocore scaffold implantation in patients with ST‐segment elevation myocardial infarction: Baseline OCT and 30‐day clinical outcomes – A FANTOM STEMI pilot study

Published:2019-07-25 Issue:1 Volume:96 Page:
ISSN:1522-1946
Container-title:Catheterization and Cardiovascular Interventions
language:en
Short-container-title:Catheter Cardiovasc Interv

Author:

Koltowski Lukasz¹,Tomaniak Mariusz¹,Ochijewicz Dorota¹,Maksym Jakub¹,Roleder Tomasz²³,Zaleska Martyna¹,Proniewska Klaudia³⁴,Opolski Grzegorz¹,Kochman Janusz¹

Affiliation:

1. 1st Department of CardiologyMedical University of Warsaw Warsaw Poland

2. Research and Development CenterRegional Specialist Hospital in Wroclaw Wroclaw Poland

3. KCRI Krakow Poland

4. Jagiellonian University Medical CollegeDepartment of Bioinformatics and Telemedicine Krakow Poland

Funder

Warszawski Uniwersytet Medyczny

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine,Radiology Nuclear Medicine and imaging,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ccd.28414

Reference12 articles.

1. A bioabsorbable everolimus-eluting coronary stent system for patients with single de-novo coronary artery lesions (ABSORB): a prospective open-label trial

2. Everolimus-eluting bioresorbable stent vs. durable polymer everolimus-eluting metallic stent in patients with ST-segment elevation myocardial infarction: results of the randomized ABSORB ST-segment elevation myocardial infarction—TROFI II trial

3. One-Year Results Following a Pre-Specified ABSORB Implantation Strategy in ST-Elevation Myocardial Infarction (BVS STEMI STRATEGY-IT Study)

4. Everolimus-Eluting Bioresorbable Scaffolds for Coronary Artery Disease

5. Intravascular ultrasound findings of the Fantom sirolimus-eluting bioresorbable scaffold at six- and nine-month follow-up: the FANTOM II study

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-term outcomes following bioresorbable vascular scaffolds;Expert Review of Cardiovascular Therapy;2024-07-30

2. Synthesis of linear polyesters bearing amino groups via lipase-catalyzed polymerization of N-protected monomer and deprotection;Polymer;2024-07

3. Scaffolds for drug delivery and tissue engineering: The role of genetics;Journal of Controlled Release;2023-07

4. Third-Generation Sirolimus‐Eluting Bioresorbable Tyrocore Scaffold Implantation in Patients with ST‐Segment Elevation Myocardial Infarction: Baseline and 6-Month OCT and Clinical Outcomes—a FANTOM STEMI Pilot Study;Cardiovascular Drugs and Therapy;2023-01-14

5. Investigating the Equivalent Plastic Strain in a Variable Ring Length and Strut Width Thin-Strut Bioresorbable Scaffold;Cardiovascular Engineering and Technology;2022-07-11